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ABSTRACT 
The biological roles of carbohydrates are particularly important in the assembly of 
complex multicellular organs and organisms, which requires interactions between cells and the 
surrounding matrix. All cells and numerous macromolecules in nature carry an array of 
covalently attached sugars (monosaccharides) or sugar chains (oligosaccharides), which are 
generically referred to as “glycans”. 
In chapter two of my dissertation, I will introduce a new approach of synthesizing sugar 
nucleotides, which is the fundamental donor for oligosaccharide synthesis. By learning and 
adapting from the industrial production, I propose to use the fermenter as an automation system 
for enzyme production and sugar nucleotide synthesis valve. In doing so, greatly increase the 
production level of nucleotide sugar donor. 
In chapter three, I will introduce the synthesis of Lewis-X containing sugar Lacto-N-
Fucopentaose III through multiple methods. LNFP III has shown great potential in the treatment 
of metabolic diseases. With the collaboration of another group, we tested multiple conjugated 
LNFP III for testing on mice. 
In chapter four, I will introduce Globo H. It is a hexasaccharide consisting of six 
monosaccharide. By using both the one pot multienzyme method and Leloir process, Globo H 
can be synthesized enzymatically without the tedious protection and purification process of 
chemical method. 
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1 CHAPTER 1. GENERAL INTRODUCTION 
1.1 Background on Glycobiology 
For many years, biological researchers have been focusing on the study and exploration of 
DNA, RNA and protein. This is mainly due to the chain of affect, where DNA can affect RNA 
which then in due affect protein. Now, more and more researchers are moving to the field of 
carbohydrate research because carbohydrates also play a non-negligible role in biological field. 
Carbohydrates or glycans are a series of molecules that play an important role in the 
forming of cells. Then can be used as energy source, signal effectors, recognition markers, and 
structural components. Carbohydrate is also one of the major post-translational modification of 
proteins. They are what makes organisms so complex. 
The study of function, structure, synthesis and biological process of glycans is called 
glycobiology.1 Glycans are fundamental components of all organisms and play important role in 
the field of medicine, biotechnology and biochemical area. 
It is important to understand the biological role of glycan in the making of cells, organs 
and organisms. All cells in nature contain a series of covalently attached monosaccharides called 
oligosaccharides. Most of these oligosaccharides are on the outer surface of cells, they are there 
to balance interactions between cells and other cell or molecules. These interactions are critical 
to the development and functions of complex organism. 
Carbohydrate drugs such as heparin are already on the market and mark the start of a new 
drug class. Also, many carbohydrates are being investigated and undergoing clinical trial as anti-
cancer drug or biomarkers.2 This new direction of drug discovery is very encouraging. 
9 
1.2 Glycosylation 
Even after many years of research, many glycans have not been assigned a function. This 
is due to the fact that more study is needed and also because of the complexity of the natural 
glycans. Over the years many evidences have been presented to support the function of specific 
glycans, but exceptions are also easily found. This furthermore proves the diversity and 
complexity of glycans.1 
Glycosylation is considered one of the most important and dominant post-translation 
modifications of protein. Glycosylation is also the main contributor to the complexity of life. 
Glycan function can be separated into two classes, the structure and modulation function 
and the identification by others. Glycans on the surface of cells can be used to be recognized by 
cells of the same organism or by other organisms. Monosaccharides are transported into the cell 
and activated to their sugar nucleotide form. Then through the Golgi, glycans are synthesized in 
sequence and expressed on the cell surface for the identification and recognition by other 
organisms.  
 
Figure 1 Glycan-Organism recognition  
10 
 There are five main classes of glycosylated glycans. N-linked glycans, O-linked glycans, 
C-linked glycans, glycolipids, and glycosylphosphatidylinositol.3 
1.2.1 N-Linked Glycans 
N-Linked glycans are glycans attached to asparagine or arginine through carbon nitrogen 
covalent bond. It is one of the two post-translational glycan modification of protein. The 
modification is important to protein in both function and structural aspect. Protein N-
glycosylation is mainly conducted in the eukaryotic system. 4 
The core structure of N-glycans is a Manα1–6(Manα1–3)Manβ1–4GlcNAcβ1–4GlcNAc 
pentasaccharide linked to asparagine by a β bond. The protein sequence of Asn-X-Ser/Thr is 
almost always present in the site of N-glycosylation. With X being any amino acid except 
proline. There are three kinds of N-glycan structures, high mannose, complex or hybrid as shown 
in figure 2.1 
 
Figure 2 Three general types of N-glycans 
11 
In the mammalian system, N-Linked glycosylation include multiple complex steps. The 
initial step of synthesis of N-glycans is the synthesis of dolichol-P-P-glycan precursor. This 
process is initiated at ER, where GlcNAc-1-P is synthesized into UDP-GlcNAc. Then a series of 
GlcNAc and five mannose will be synthesized on to the initial GlcNAc to form the seven sugar 
Man5GlcNAc2-P-P-Dol core. The second part of the synthesis is transferred to the luminal side 
of the ER membrane where 4 mannose and 3 glucose are added to the core to finally form 
Glc3Man9GlcNAc2-P-P-Dol. After the precursor is synthesized, it is transferred to the nascent 
proteins where it is attached to the asparagine in Asn-X-Ser/Thr (X can be any amino acid except 
proline). After the oligosaccharide is attached to the peptide, an initial trimming reaction is done 
in the ER. The terminal glucose is removed by α-glucosidases I and II. After removal of the three 
glucose, the whole molecule is transferred to the Golgi. Within the Golgi the four mannose with 
α-1,2 linkages will all or partially removed. Then other sugar will be added to form the three 
types of N-Glycans.5 
N-Glycans can be released from the glycoprotein by PNGase F, in doing so asparagine 
will be converted to aspartic acid. This is often used to identify the N-Glycan site. After release 
of the N-Glycans, it can be purified by HILIC column, PGC and other methods. Further analysis 
can be done using mass spectrometry. 6 
Alteration of the N-glycan can be associated with many diseases such as cancer, 
Alzheimer’s disease, diabetes and many more. With every new study of N-glycans we learn 
more and more about it. 
1.2.2 O-Linked Glycans 
O-link glycosylation is another form of glycosylation for post-translational modification 
of protein. It is the attachment of glycan to serine or threonine through a carbon-oxygen covalent 
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bond. One type of O-linked glycan is the O-GalNAc glycans also known as Mucin-type O-
glycans. Mucin O-glycan is a GalNAc covalently bond to serine or threonine through an α-
linkage. Mucin O-glycan are found on proteins in mucous secretion located at cell surface and 
body fluids.7 
Unlike N-glycans which have a universal core structure, the O-glycans is separated in to 
eight core structures as shown in figure 3. Also different from N-glycans, most O-glycans 
doesn’t have an obvious sequence for the site of O-Glycans. 
 
Figure 3 Core structure of O-glycans 
 Mucin was first proven to be glycoprotein by Russian physician E. Eichwald in 1865. In 
O-glycans, it mainly consists of Gal, GlucNAc, Fuc and/or sialic acid. There is no Man, Glc, or 
Xyl to be found within the structure.  
13 
 The biosynthesis pathway of O-glycan starts with the transfer of GalNAc from UDP-
GalNAc to serine or threonine. This process is done by the enzyme polypeptide-N-acetyl-
galactosaminyltransferase (ppGalNAcT). Depending on the core structure of different O-glycan, 
the next sugar attached could be Gal, GlcNAc or GalNAc. It is very dependent of the cell where 
the glycosylation is taking place. For example, it is common to find just GalNAc connected to 
serine or threonine (Tn antigen) in tumors, this shows that the synthesis of O-glycan could be 
blocked in these cancer cells.  
 For the synthesis of Core 1, a Gal is connected to the Tn antigen by a  1-3 bond. This is 
catalyzed by enzyme C1GalT-1. Core 2 is Core 1 branched one sugar further by the attachment 
of GlcNAc. Reaction is catalyzed by enzyme C2GnT. The extension to Core 2 often correspond 
to tumor progression since the attached sugar on the branch can block mucin peptide epitopes 
from being exposed.  
 Core 3 synthesis usually take place at gastrointestinal, respiratory tracts and salivary 
glands. Core 3 is synthesized by an addition of GlcNAc by C3GnT enzyme to the  1-3 position 
of GalNAc. Core 3 can be extended further to Core 4 by addition of GlcNAc to the  1-3 
position of GalNAc. This reaction is done through the enzyme C2GnT. Core 5 to Core 8 are 
considered uncommon core structure and their biopathway needs to be further characterized and 
investigated.1 
 Analysis of O-glycans are often done after they are released from the protein by a β-
elimination process. This process will not affect N-glycans and will solely release O-glycans. 
Then, the released O-glycans can be separated by chromatography method and experimented for 
structural analysis. 
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1.2.3 C-Linked Glycans 
C-linked glycosylation was first reported by Jan Hofsteenge in 1996. C-glycosylation is 
also known as C-mannoslyation, is fundamentally different than other type of glycosylation. It is 
a mannose attached to tryptophan in the sequence of Trp-X-X-Trp, where X can be any amino 
acid. The linkage here is α-linkage of C-C bond instead of carbon attaching to more active 
atoms. The first crystal structure of protein containing C-glycosylation was human complement 
component 8.8 
 
Figure 4 Structure of C- mannosylation 
With the sequence known for C-mannosylation, a database search showed that 336 
proteins in mammalian cells examine the potential for C-mannosylation. These proteins are 
widespread in many different organs and body fluids, this proves that C-mannosylation is a 
common protein modification. The biosynthetic pathway of C-mannosylation starts with the 
conversion of mannose to GDP-Man to Dol-P-Man in the ER. Then mannose will be attached to 
the peptide.9  
1.2.4 Glycolipid 
Glycolipids are glycans linked to a lipid aglycone. The main glycolipid is a class called 
glycosphingolipids (GSL). It is widely found in the cell membranes and is the major form of 
glycoconjugates in the brain. 
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Glycosphingolipids play an important role on cell surfaces. It affects neuronal plasticity 
during development, adulthood and aging. It regulated immunological function and is often 
related to cancer progression. Viruses and pathogenic bacteria adhesins can recognize 
glycosphingolipids for host cell invasion.1 
Glycolipid was initially characterized in 1884 by using the structure of 
galactosylceramide. It is one of the simplest structure glycolipid and found extensively in the 
brain.  
The core structure of glycosphingolipids is consistent with the structure of  linked 
Gal/Glc-Cer, where Gal-Cer is mainly found in the brain and Glc-Cer is found in tissue. In 
vertebrate GSL there are five subfamilies with different core structure, but they all have Gal-Glc-
Cer as the first three compound. These glycosphingolipid subfamilies are called Ganglio, Lacto, 
Neo-lacto, Globo and Isoglobo. There structures are listed below.  
Table 1 Glycosphingolipid subfamilies and structure. 
Subfamily Core structures 
V IV III II I 
 
Ganglio (Gg) 
   
Gal1–4 Glc Cer   
GalNAc1–4 Gal1–4 Glc Cer  
Gal1–3 GalNAc1–4 Gal1–4 Glc Cer 
Lacto (Lc) 
 
Gal1–3 GlcNAc1–3 Gal1–4 Glc Cer 
Neo-lacto 
(nLc) 
 
Gal1–4 GlcNAc1–3 Gal1–4 Glc Cer 
Globo (Gb) Gal1–3 GalNAc1–3 Gal1–4 Gal1–4 Glc Cer 
Isoglobo (iGb) Gal1–3 GalNAc1–3 Gal1–3 Gal1–4 Glc Cer 
The biosynthesis of GSL occurs in a stepwise fashion in the ER and Golgi. First ceramide 
is synthesized in the ER and then transferred to the luminal face and then to the Golgi. Glc-Cer 
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and Gal-Cer are synthesized separately at either the cytoplasmic face or the luminal face. Then 
both are transferred to the Golgi to be elongated by glycosyltransferases. After all glycosylation 
synthesis is done, both will be expressed on the plasma membrane.10 
Chemical method is often used to extract glycolipids from tissues and cells. After initial 
separation by organic extraction and solvent partition, HPLC is often used as a last step for the 
separation and purification of glycolipids. Glycan composition of the glycolipid can be done by 
the release of glycan from lipid then analysis of the monosaccharide. Mass spectroscopy is often 
used to determine the sequence of the glycans on the glycolipid.  
1.2.5 Glycosylphosphatidylinositol 
Glycosylphosphatidylinositol (GPI) is a glycolipid that can link to protein through the 
protein’s C-terminal. The lipid bilayer is where most of the proteins attached to GPIs are found. 
In 1963 is when GPI is first suggested with data proof, which showed the selective release of 
alkaline phosphatase from mammalian cells by crude bacterial phospholipase C. In mid 70s, 
phosphatidylinositol-protein was proposed as a hypothesis, and confirmed by 1985. The first GPI 
structure was solved in 1988.11 
The core structure of GPI anchors is consist of three parts, ethanolamine for the 
connection of protein, Man-Man-Man as the connecting backbone, and phosphatidylinositol part. 
Mannose is attached to the protein carbon terminal by the C-6 hydroxyl group through 
ethanolamine. On the other end is connected to the GlcNAc through  1-4 bond.1 
17 
 
Figure 5 General core structure of GPI anchors. 
The biosynthesis of GPI is mainly done in the ER and the Golgi. First, the GPI precursor 
is preassembled in the membrane of the ER, then the GPI is attached to the protein in the lumen 
area. Last, the modeling of carbohydrate is done in the ER and the Golgi. 
In humans, if the GPI-anchor synthesis has deficiency, it is often caused by rare diseases 
such as paroxysmal nocturnal hemoglobinuria (PNH) and hyperphosphatasia with mental 
retardation syndrome (HPMRS).12  
1.2.6 Biological Importance of Sugar Nucleotide 
As previously described in all glycosylation method, all elongation of glycans need the 
fundamental building block of sugar nucleotide. With the help of Leloir transferase, sugar 
nucleotide donors can specifically transfer the sugar to sugar chain with targeted connectivity. 
18 
Any malfunction in the synthesis of sugar nucleotide will cause the glycosylation process 
to be altered or utterly stopped. This can lead to a wide variety of disease and sickness. In order 
to study glycosylation function and structure, it is crucial to have the ability to synthesize all 
sugar nucleotide at a large scale with high purity.13 
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2 CHAPTER 2. SYNTHESIS OF COMMON SUGAR NUCLEOTIDE BY 
FERMENTATION 
2.1 Introduction 
Nucleotide sugars are the activated forms of monosaccharides. They act as the essential 
donor for glycosylation reactions. In table 1 is shown the 11 common nucleotide sugars found in 
nature.14  
Table 1 11 Common Sugar Nucleotides 
UDP-Sugar GDP-Sugar CMP-Sugar 
UDP-Glc GDP-Fuc CMP-Neu5Ac 
UDP-Gal GDP-Man CMP-New5Gc 
UDP-GlcNAc 
  
UDP-GalNAc 
  
UDP-GlcA 
  
UDP-GalA 
  
UDP-Xylose 
  
 
In order for a glycosylation reaction to happen, the donor monosaccharides should exist in a 
highly energetic form. The activated monosaccharide can be produced by first reacting with ATP 
to form monosaccharide-1-phosphate, then react with UTP or GTP to form activated nucleotide 
sugar (except for sialic acid). For sialic acid, it can react directly with CTP to form the activated 
20 
form of CMP-sialic acid. The overall mechanism scheme of sugar nucleotide synthesis is shown 
in figure 1.  
 
Figure 6 Overall reaction mechanism of sugar nucleotides 
Nucleotide sugars are the essential donors for biosynthesis of glycans and 
glycoconjugates. Glycans and glycoconjugates are commonly found in nature15 and play an 
essential role in cell-cell recognition, cell differentiation, and immunological responses.16-18  
In nature, even though there are many different kinds of glycans acting as different functions, 
they mainly consist of eleven common nucleotide sugars. Among the eleven, only nine nucleotide 
sugars are commonly used in mammalian cells.19  
2.2 Background on Enzymatic Synthesis of Nucleotide Sugar 
Enzymatic methods including in situ regeneration cycles are more attractive method of 
producing nucleotide sugar compared with chemical method. These regeneration cycles not only 
reduce the cost of sugar nucleotides, but also lessen the problem of product inhibition caused by 
the resulting nucleoside phosphates. 
Two kinds of biosynthetic pathways for nucleotide sugar exist in nature:  
21 
De novo pathway: refers to the synthesis of nucleotide sugars from the central 
monosaccharide in carbohydrate metabolism (Glc) and nucleotides. It usually requires several 
enzymes and certain co-factors and will generate several intermediates that has similar structures 
with the product. Nucleotide sugars generated by these pathways cannot be easily separated.20  
Salvage pathway: is a pathway in which nucleotide sugars are synthesized from 
monosaccharides generated in glycan degradative pathway. It recycles the intracellular sources 
of monosaccharides, and usually involves two enzyme-catalyzed steps: (A) a kinase-catalyzed 
formation of monosaccharide 1-phosphate from the corresponding monosaccharide and ATP; (B) 
a pyrophosphorylase-catalyzed formation of nucleotide sugar and pyrophosphate byproduct from 
nucleotide triphosphate and the monosaccharide 1-phosphate.21 
2.3 Background on Chemical Synthesis of Nucleotide Sugar 
Unlike enzymatic synthesis, chemical synthesis needs to undergo many tedious steps such 
as protection and deprotection of the monosaccharide. But compared with enzymatic synthesis 
which is limited to the kinase and transferase that we have discovered, chemical synthesis is the 
option for unnatural nucleotide sugar synthesis. Also, for low activity enzymatic reactions, we 
can use chemical reactions to replace enzymatic reactions such as the synthesis of UDP-Xylose 
uses chemical reaction to synthesize xylose-1-phosphate.22 
The general strategy for synthesizing nucleotide sugar is either to first synthesize sugar-1-
phosphate then react with nucleotide monophosphate with a leaving group. Or synthesize sugar 
with leaving group then react with nucleotide diphosphate.23  
22 
 
Figure 7 General strategy for chemical synthesis of nucleotide sugar. 
2.4 Background on Industrial Production of Nucleotide Sugar 
Kyowa Technology has been able to produce sugar nucleotides at large scale using 
recombinant E. coli cells. Using the fermentation method, they were able to produce 43.9 g/L 
UDP-Glc in the fermenter. An example of their recombinant E. coli is shown below. 
 
Figure 8 Recombinant E. coli for the production of UDP-Glucose 
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 Purification of nucleotide sugars by Kyowa Technology is done by first using ionic 
exchange chromatography to separate nucleotide sugars then using activated carbon to desalt the 
collected fractions.24, 25  
For all enzymatic reactions, in order to achieve industrial scale production, it is essential 
to use the fermentation equipment to upscale a reaction. It is more automatic and more 
economical.  
2.5 Synthesis: One Pot Multienzyme Synthesis of Common Nucleotide Sugar 
2.5.1 Enzymatic Synthesis of Nucleotide Sugar 
In order to enzymatically synthesize nucleotide sugar, the first step is to have ATP convert the 
monosaccharide from monosaccharide to monosaccharide one phosphate. After the one 
phosphate sugar is produced, the nucleotide is added to form nucleotide sugar. PH is adjusted 
either by Tris-HCl buffer, sodium hydroxide or ammonium hydroxide. Reaction is usually done 
under 37 degrees with overnight shaking. After reaction, enzyme is removed either by boiling or 
50% ethanol. Purification can be done by ionic exchange chromatography, CIP digestion, barium 
precipitation and/or P2 column. To simplify the production process, one-pot multi-enzyme 
(OPME)26 strategy is used. Enzymes involved in the multi-step reaction of nucleotide sugar 
synthesis will be combined in one reaction pot with monosaccharides and nucleotides. This can 
be done with a sugar transferase for the synthesis of oligosaccharide reaction. 
2.5.2 Overexpression of Enzymes 
Escherichia coli containing the enzyme protein expression gene was added to 50 mL LB 
Broth medium containing antibiotics (100 mg/mL ampicillin or 50 mg/mL kanamycin) under 
sterile environment for overnight shake. After 16 hours, everything was transferred to a 2 L LB 
Broth medium solution containing antibiotics at 37 °C in a sterile environment. When the OD600 
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value reached 0.8, solution was be let to cool till room temperature. Then IPTG was added to a 
final concentration of 0.4 mM, protein expression was allowed to proceed for 20 hour at 16 °C. 
Cells were harvested by centrifugation (4,000 rpm, 30 min, 4 °C) and washed with Tris-HCl 
buffer (50 mM, pH 8.0). The cell pellets were resuspended in chilled lysis buffer (20 mM 
imidazole, 0.3 M NaCl, 20 mM Tris-HCl buffer, pH 8.0) and lysed by brief sonication on ice or 
French press. After centrifugation (13,000 rpm, 50 min, 4 °C) of the cell lysate, the supernatant 
was filtered (0.45 μm) and is ready for nickel affinity column purification.  
2.5.3 Enzyme Purification using Nickel Affinity Column 
For both enzymatic reactions, access to proteins at large amount and high purity is 
essential. Many methods are used in the field of protein purification. For example, metal binding, 
size exclusion chromatography, hydrophobic interaction chromatography, ion exchange 
chromatography and etc.27 
For my research, I use metal binding for the purification of enzymes, specifically using 
nickel affinity column. The reason why I choose nickel affinity column is that it is convenient to 
use, easy to get access and time efficient. A nickel affinity column is used to bind with the HIS-
tag in the enzyme for purification. 
The column was first washed with 10 column volume of washing buffer (5~40 mM 
imidazole, 0.5 M NaCl, 20 mM Tris-HCl buffer, pH 8.0) and afterwards the enzyme was eluted 
with 5 column volume of elution buffer (300 mM imidazole, 0.3 M NaCl, 20 mM Tris-HCl 
buffer, pH 8.0). The fractions containing the purified enzyme were combined and the buffer was 
exchanged to Tris-HCl buffer (20 mM, pH 7.5, 10% glycerol) using Amicon Ultra and stored at -
20 °C. The whole process is shown in figure 4. 
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Figure 9 Enzyme purification using nickel affiliation column. 
The enzymes expressed in our lab are modified to have six His-tag at the end of the 
protein. The main principle of the Ni-NTA protein purification system is based on Ni-NTA 
(nickel-nitrilotriacetic acid) resin interacts with the enzyme proteins that contains the His-tag 
affinity tag we purposely attached.28 In figure 5 shows the mechanism for histidine interaction 
with nickel. 
 
Figure 10 Mechanism of histidine interaction with nickel-NTA resin. 
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The nitrogen in the histidine ring forms a covalent bond with the nickel. Since His-tag 
consist of six adjacent histidine it will form a very strong bond with the column. After other 
impurities and none His-tag proteins have been washed away by low concentration imidazole 
lysis solution. High concentration of imidazole is used to elute the His-tag protein, because 
imidazole also has nitrogen containing ring which can bind with the nickel. In doing so, it will 
replace the enzyme, thus, eluting the enzyme into solution. 
2.5.4 Thin-layer Chromatography  
Thin-layer chromatography (TLC) is a technique often used to monitor the progress of 
reactions.29 I use the silica gel as stationary phase and isopropanol/H2O/ammonium hydroxide = 
7:3:2 (v/v/v) as mobile phase. For sugar nucleotides which has UV absorption, can be checked 
by using a 254 nm UV lamb. 
2.5.5 Purification of nucleotide sugars 
The most commonly used method of nucleotide sugar purification is by size exclusion 
chromatography. It is easy to operate, clean result without introducing other impurities and cheap 
to use. But it is also the limiting step for large-scale preparation of sugar nucleotides because the 
loading volume of sample for the column is limited to about 1% of column volume. The sample 
cannot be over concentrated due to the solubility limit of salts in the sample or the separation 
efficiency limit of the SEC column. Therefore, other easy-to-scale-up purification techniques can 
be used instead of SEC or combined with SEC is highly demanded and will greatly push large-
scale preparation of nucleotide sugars forward. Here, we propose to use scalable chromatographic 
techniques, such as anion exchange chromatography (AEC), CIP digestion or barium precipitation 
method. The above methods can cooperate with P2 purification for larger scale and high purity 
purification. 
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Enzyme removal: After the reaction is finished, enzyme removal is the first step of 
purification process. Enzymes will precipitate from the reaction by heating the reaction mixture to 
90 degrees for 10 minutes. Another option is to add ethanol to 50% concentration then kept at -20 
degrees for 2 hours followed by centrifugation for non-heat resistant nucleotide sugar. CIP 
digestion can be performed to remove excess ADP and other residual nucleotides, because they 
have similar polarity and molecular weight with nucleotide sugars. After thorough degradation of 
the nucleotide remained in the reaction mixture, CIP will be removed by heating and 
centrifugation. 
Ionic Exchange Chromatography: Ion-exchange chromatography is the most commonly 
used chromatography for large scale nucleotide sugar purification. The mechanism of ionic 
exchange chromatography is to separate molecules based on their charge. Compounds with counter 
charges to the column resin will retain on the column, while same charged or neutral compounds 
will elute. The higher the charge the stronger the bond will be between analyte and resin. Then 
using different concentration of salt can elute the compounds starting from lowest charge 
chemicals. 
In my experiment, I used the HiTrap Q HP resin. It is a strong anion exchange 
chromatography resin I packed into a 50 mL column for gram scale purification of nucleotide 
sugars. The functional group on the resin is an amino group. The more negative charged 
compounds will be eluted last, salt and sugar will elute first. 
Using water as solvent A and 500 mM sodium chloride as solvent B I can separate 
nucleotide sugar from other impurities. After equilibration of the column, use 2% B to wash out 
the low charged molecules. Using a UV detector to monitor the elution pattern. After low charge 
molecules are eluted, escalate to 6% B to elute nucleotide sugar. At this point, the high charged 
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molecules such as ATP, UTP and ADP are still retaining on the column. After all nucleotide sugar 
are eluted, wash the column with 15% B to elute high charged molecules. The elution pattern is 
shown in the figure below.30 
Collect all fractions with nucleotide sugars and concentrate to small volume. Then load the 
solution on to P2 column for desalting.  
 
Figure 11 Ionic exchange purification of nucleotide sugar. 
Precipitation method: BaCl2 can be used for sugar nucleotides precipitation by Ba ion 
combined with the free phosphate group in the nucleotide. The procedure is quenched the synthetic 
reaction by boiling at 90℃ for 10 min. Transfer sample to beaker containing a stir bar and place 
on magnetic stirrer. While sample is stirring, slowing add appropriate amount 1M （barium 
chloride） BaCl2 solution. Transfer to conical tube and centrifuge at 13,000 for 5 min to remove 
precipitate. Adjust pH to 7. Repeat step 3 and 4 until no further precipitate formed, then centrifuge 
at 13,000 for 20 min. Apply the concentrated supernatant to Bio-rad P2 gel filtration to remove 
extra salts.31 
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CIP Digestion 
Alkaline phosphatase or calf intestinal alkaline phosphatase is an enzyme that can be used 
to remove the phosphate group from the nucleotide. It won’t affect nucleotide sugar due to the 
sugar protecting the phosphate group. A big problem with P2 purification of nucleotide sugar is 
caused because ATP and other nucleotides have similar molecular weight as nucleotide sugars. By 
removing the phosphate group from them, it greatly lowers their molecular weight, which in turn 
increase the resolution of P2 separation. 
P-2 Biogel Purification 
In my research of sugar nucleotide and glycan synthesis, because of the large mass 
difference of my starting material and product, a size exclusion chromatography (SEC) is often 
used for purification. A size exclusion chromatography has many advantages, such as, we use 
water as mobile phase, and this will prevent introducing new salts compared with ionic exchange 
chromatography. Also, since the mass difference is usually more than 100, it is very easy to get 
good separation of starting material and product. Though, sometimes we need an excess step to 
increase the mass difference. One drawback of SEC is that molecules with similar mass is very 
hard to separate and the time it takes is very long in order to get optimal separation. In figure 7 
shows the flow chart of size exclusion chromatography run. 
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Figure 12 Flow chart of size exclusion chromatography. 
Size exclusion chromatography was initially discovered by Grant Henry Lathe and Colin 
R Ruthven.32 The first column was made of starch gels. Later on, many other great scientists has 
discovered different gels and pushed this technique forward. In my research, I use the Bio Gel 
P2, it is made of polyacrylamide beads with separation for molecules under 1800 Dalton.  
The mechanism of SEC separation is dependent of the molecule size. The bigger the 
molecule, the easier it will elute from the column. SEC is a great way and also commonly used 
way for desalting a compound. There are many small holes of different size within the column, 
the smaller column will be trapped inside the holes while large molecules can just pass without 
being trapped. Thus, the smaller the molecule, the longer the retention time will be. Since the 
mobile phase is deionized water, SEC purification brings in no other impurities to the compound 
being purified. 
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There are two rules for SEC, one is that the compounds being separated can not interact 
with the stationary phase. Making sure the elution time is only dependent of the molecular size. 
Another rule is the compounds being separated can not be larger than the set limit, otherwise 
they will have no retention and elute at the same time.33 As shown in figure 8. Is the mechanism 
for SEC. 
 
Figure 13 Mechanism for size exclusion chromatography. 
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2.5.6 Production of Sugar Nucleotides 
Production of UDP-Glc 
In preparation of UDP-Glucose, UTP will be weighed and dissolved in deionized water, 
and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole of 
glucose-1-phosphate will be weighed and added into the solution and mixed well. To start with 
glucose-1-phosphate is because it is cheaper than ATP. Excessive amount of glucose-1-phosphate 
is used to deplete the UTP, which have similar polarity and molecular weight with the product 
UDP-Glucose, to simplify the purification process. Next, Tris-HCl buffer (pH 8) and MgCl2 
solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, followed by 
adding enzymes (BLUSP and PPA) into the mixture. USP act as a nucleotidyltransferase to convert 
the glucose one phosphate to UDP-Glc.34 Since the reaction is reversible, PPA is added to digest 
the diphosphate byproduct.35 It also increase yield by driving the reaction forward. The reaction 
mixture will be incubated at 37oC for 1 to 2 days (d). The reaction is monitored by thin-layer 
chromatography (TLC). When no further generation of UDP-Glucose is observed, the reaction 
will be terminated by heating the reaction mixture in boiling water for 5-10 minutes and 
centrifuged to get rid of the enzyme. Then reaction solution is rotavapped to small volume for 
further purification by ionic exchange and P2 column. 
 
Figure 14 Enzymatic reaction scheme for UDP-Glc 
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Production of UDP-Gal 
In preparation of UDP-Gal, ATP and UTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of galactose will be weighed and added into the solution and mixed well. Excessive amount of 
galactose is used to deplete the ATP and UTP, which have similar polarity and molecular weight 
with the product UDP-Gal, to simplify the purification process. Next, Tris-HCl buffer (pH 8) and 
MgCl2 solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, 
followed by adding enzymes (EcGalk, BLUSP and PPA) into the mixture. Galk the kinase will 
convert Gal to Gal-1-P, then USP will further convert gal-1-P to UDP-Gal.36 PPA is added to 
prevent counter reaction. The reaction mixture will be incubated at 37oC for 1 to 2 days. The 
reaction is monitored by thin-layer chromatography (TLC). When no further generation of product 
is observed, the reaction will be terminated by heating the reaction mixture in boiling water for 5-
10 minutes and centrifuged to get rid of the enzyme. Then reaction solution is rotavapped to small 
volume for further purification by ionic exchange and P2 column. 
 
Figure 15 Enzymatic reaction scheme for UDP-Gal 
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Production of UDP-GlcNAc 
In preparation of UDP-GlcNAc, ATP and UTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of GlcNAc will be weighed and added into the solution and mixed well. Excessive amount of 
galactose is used to deplete the ATP and UTP, which have similar polarity and molecular weight 
with the product UDP-GlcNAc, to simplify the purification process. Next, Tris-HCl buffer (pH 8) 
and MgCl2 solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, 
followed by adding enzymes (NahK, GlmU and PPA) into the mixture. Nahk the kinase will 
convert GlcNAc to GlcNAc-1-P,37 then GlmU will further convert GlcNAc-1-P to UDP-
GlcNAc.38 PPA is added to prevent counter reaction. The reaction mixture will be incubated at 
37oC for 1 to 2 days. The reaction is monitored by thin-layer chromatography (TLC). When no 
further generation of product is observed, the reaction will be terminated by heating the reaction 
mixture in boiling water for 5-10 minutes and centrifuged to get rid of the enzyme. Then reaction 
solution is rotavapped to small volume for further purification by ionic exchange and P2 column. 
 
Figure 16 Enzymatic reaction scheme for UDP-GlcNAc 
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Production of UDP-GalNAc 
In preparation of UDP-GalNAc, ATP and UTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of GalNAc will be weighed and added into the solution and mixed well. Excessive amount of 
galactose is used to deplete the ATP and UTP, which have similar polarity and molecular weight 
with the product UDP-GalNAc, to simplify the purification process. Next, Tris-HCl buffer (pH 8) 
and MgCl2 solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, 
followed by adding enzymes (NahK, AGX1 and PPA) into the mixture. NahK the kinase will 
convert GalNAc to GalNAc-1-P, then AGX1 will further convert GalNAc-1-P to UDP-GalNAc.39 
PPA is added to prevent counter reaction. The reaction mixture will be incubated at 37oC for 1 to 
2 days. The reaction is monitored by thin-layer chromatography (TLC). When no further 
generation of product is observed, the reaction will be terminated by heating the reaction mixture 
in boiling water for 5-10 minutes and centrifuged to get rid of the enzyme. Then reaction solution 
is rotavapped to small volume for further purification by ionic exchange and P2 column. 
 
Figure 17 Enzymatic reaction scheme for UDP-GalNAc 
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Production of UDP-GlcA 
In preparation of UDP-GlcA, ATP and UTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of GlcA will be weighed and added into the solution and mixed well. Excessive amount of GlcA 
is used to deplete the ATP and UTP, which have similar polarity and molecular weight with the 
product UDP-GlcA, to simplify the purification process. Next, Tris-HCl buffer (pH 8) and MgCl2 
solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, followed by 
adding enzymes (GlcAK, USP and PPA) into the mixture. GlcAK the kinase will convert GlcA to 
GlcA-1-P,40 then USP will further convert GlcA-1-P to UDP-GlcA. PPA is added to prevent 
counter reaction. The reaction mixture will be incubated at 37oC for 1 to 2 days. The reaction is 
monitored by thin-layer chromatography (TLC). When no further generation of product is 
observed, the reaction will be terminated by heating the reaction mixture in boiling water for 5-10 
minutes and centrifuged to get rid of the enzyme. Then reaction solution is rotavapped to small 
volume for further purification by ionic exchange and P2 column. 
 
Figure 18 Enzymatic reaction scheme for UDP-GlcA 
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Production of UDP-GalA 
In preparation of UDP-GalA, ATP and UTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of GalA will be weighed and added into the solution and mixed well. Excessive amount of GalA 
is used to deplete the ATP and UTP, which have similar polarity and molecular weight with the 
product UDP-GalA, to simplify the purification process. Next, Tris-HCl buffer (pH 8) and MgCl2 
solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, followed by 
adding enzymes (GalK, USP and PPA) into the mixture. GalK the kinase will convert GalA to 
GalA-1-P, then USP will further convert GalA-1-P to UDP-GalA. PPA is added to prevent counter 
reaction. The reaction mixture will be incubated at 37oC for 1 to 2 days. The reaction is monitored 
by thin-layer chromatography (TLC). When no further generation of product is observed, the 
reaction will be terminated by heating the reaction mixture in boiling water for 5-10 minutes and 
centrifuged to get rid of the enzyme. Then reaction solution is rotavapped to small volume for 
further purification by ionic exchange and P2 column. 
 
Figure 19 Enzymatic reaction scheme for UDP-GalA 
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Production of GDP-Fuc 
In preparation of GDP-Fuc, ATP and GTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of fucose will be weighed and added into the solution and mixed well. Excessive amount of fucose 
is used to deplete the ATP and UTP, which have similar polarity and molecular weight with the 
product GDP-Fuc to simplify the purification process. Next, Tris-HCl buffer (pH 8) and MgCl2 
solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, followed by 
adding enzymes (FKP and PPA) into the mixture. FKP here acts as both the kinase and 
nucleotidyltransferase.41 It will convert Fuc to Fuc-1-P, then further convert to GDP-Fuc. PPA is 
added to prevent counter reaction. The reaction mixture will be incubated at 37oC for 1 to 2 days. 
The reaction is monitored by thin-layer chromatography (TLC). When no further generation of 
product is observed, the reaction will be terminated by adding pure ethanol to the reaction till 50%. 
Then whole solution will be kept at -20 freezer to precipitate the enzyme because GDP-Fuc is not 
very heat tolerant and may decompose. After 3 hours, the solution is centrifuged to get rid of the 
enzyme. Then reaction solution is rotavapped to small volume for further purification by ionic 
exchange and P2 column. 
 
Figure 20 Enzymatic reaction scheme for GDP-Fuc 
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Production of GDP-Man 
In preparation of GDP-Man, ATP and GTP will be weighed and dissolved in deionized 
water, and the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole 
of Mannose will be weighed and added into the solution and mixed well. Excessive amount of 
Mannose is used to deplete the ATP and UTP, which have similar polarity and molecular weight 
with the product GDP-Man to simplify the purification process. Next, Tris-HCl buffer (pH 8) and 
MgCl2 solution will be added into the solution to a final concentration of 0.1 M and 0.02 M, 
followed by adding enzymes (NahK, ManC and PPA) into the mixture. NahK the kinase will 
convert Man to Man-1-P, then ManC will further convert Man-1-P to GDP-Man.42 PPA is added 
to prevent counter reaction. The reaction mixture will be incubated at 37oC for 1 to 2 days. The 
reaction is monitored by thin-layer chromatography (TLC). When no further generation of product 
is observed, the reaction will be terminated by heating the reaction mixture in boiling water for 5-
10 minutes and centrifuged to get rid of the enzyme. Then reaction solution is rotavapped to small 
volume for further purification by ionic exchange and P2 column. 
 
Figure 21 Enzymatic reaction scheme for GDP-Man 
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Production of CMP-Neu5Ac 
In preparation of CMP-Neu5Ac, CMP will be weighed and dissolved in deionized water, and 
the pH of the solution will be adjusted by NaOH to pH 7.5. Then, 1.1 equivalent mole of Neu5Ac 
will be weighed and added into the solution and mixed well. Excessive amount of Neu5Ac is used 
to deplete the CTP, which have similar polarity and molecular weight with the product CMP-
Neu5Ac to simplify the purification process. Next, Tris-HCl buffer (pH 8) and MgCl2 solution will 
be added into the solution to a final concentration of 0.1 M and 0.02 M, followed by adding 
enzymes (CSS and PPA) into the mixture. CSS here acts as nucleotidyltransferase and directly add 
CMP to Neu5Ac to form CMP-Neu5Ac without the help of ATP.43 PPA is added to prevent 
counter reaction. The reaction mixture will be incubated at 37oC for 3 hours. The activity of CSS 
is very high and the stability of CMP-Neu5Ac is low, thus the reaction needs to be monitored by 
thin-layer chromatography (TLC) very closely. When no further generation of product is observed, 
the reaction will be terminated by adding pure ethanol to the reaction till 50%. Then whole solution 
will be kept at -20 freezer to precipitate the enzyme because CMP-Neu5Ac is not very heat tolerant 
and may decompose. After 3 hours, the solution is centrifuged to get rid of the enzyme. Then 
reaction solution is rotavapped to small volume for further purification by ionic exchange and P2 
column. 
 
Figure 22 Enzymatic reaction scheme for CMP-Neu5Ac 
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Capillary Electrophoresis Condition 
Capillary electrophoresis (CE) separates ions depending of their charge and size. With 
applied voltage, the ions with opposite charge of the direction of the flow will elute first and same 
charge will elute last due to ionic forces.44 CE-UV is used in my experiment to check the purity of 
compounds. The condition is first rinse with filtered 0.1 M NaOH, then the column is rinsed with 
deionized water, lastly the column will be rinsed by the running buffer (sodium tetraborate 0.05 
M, pH 9.3). Injection is done by pressure injection at 0.5 psi for 5 seconds. The whole separation 
is done at 25.0 KV for 25 min with a 0.17 min ramping time. UV detection is set to 254 nm for 
optimal observation. 
MALDI-TOF 
MALDI-TOF is using matrix-assisted laser desorption/ionization (MALDI) as the 
ionization method and time of flight (TOF) as detection method.45 The matrix used in my 
experiment is 2,5-Dihydroxybenzoic acid (DHB). It is commonly used for carbohydrates and other 
small molecules. The advantage of MALDI compared to other ionization techniques is that it is a 
soft ionization method, which will not break the initial molecule and cause fragmentation. It will 
also give spectrums with typically one charge. 
MALDI-TOF is a multistep analysis. Initially, the matrix is mixed with the sample and applied 
to a metal plate for crystallization. Then the crystallized compound and plate is injected into the 
MALDI machine and the laser ionize the sample. Then the sample will be shot into TOF for 
analysis.46 
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Figure 23 Structure of 2,5-Dihydroxybenzoic acid (DHB) 
Enzyme immobilization 
Enzymes are naturally existing catalyst that accelerate the reactions of biological life. 
They can increase the reaction rate to millions time faster with extremely high specificity due to 
their unique three-dimensional structure. 
In order to apply many of enzymes great advantages to a larger field of use, one 
disadvantage of the enzyme needs to be conquered, which is the high expense of producing 
enzyme. Many methods have been proposed and one method that is commonly used is enzyme 
immobilization.47  
Enzyme immobilization is to physically confine or localize enzymes in a certain defined 
region of space with retention of their catalytic activities, and which can be used repeatedly and 
continuously.48 Due to the fact that immobilized enzyme can be easily removed from reaction 
solution and reused multiple times, it can remarkably reduce the cost of enzyme and the 
enzymatic products.  
Many other benefits also come from immobilizing enzymes such as, (1) rapid stop of the 
reaction by simply removing the enzyme and (2) improve enzyme stability against temperature, 
solvents, pH, contaminants and impurities. (3) It also helps for efficient recovery and reuse of 
expensive enzymes.49 
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Enzyme production is also a big problem for large scale synthesis of nucleotide sugar, the 
expression and purification process of producing enzyme is time consuming and tedious. Here I 
propose to use a total of 5 resins to immobilize NahK and AGX1 for the synthesis of UDP-
GalNAc. The general procedure for doing so is first equilibrate the resin using buffer. Then load 
the protein onto the resin. After reaction, excess enzyme are washed away by washing buffer 
multiple times. 
For each immobilization procedure, 50 mg of resin was used. A total of 2.5 mg of 
specific resin was added to the 2 mL solution. The initial concentration of enzymes was 5 
mg/mL for NahK and 2 mg/mL for AGX1. After adding to solution, all concentration was at 
1.25 mg/mL as shown in the chart below. 
Table 2. Initial Enzyme Amount Ready for Loading 
 
NahK AGX1 
50 mg resin 500 ul 1.25 ml 
 
2.5 mg enzyme 2.5 mg enzyme 
 
Figure 24 Standard curve made by BCA standard for quantification of enzyme 
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After immobilization, the concentration of enzymes were calculated again and amount 
binding was calculated as shown in the chart below. 
Table 3. Final Enzyme Concentration and Loaded Amount 
 
NahK AGX1 
 
Macroporous styrene Macroporous styrene 
Concentration (mg/mL) 0.35 0.479 
Amount connected (mg) 0.4375 0.958 
 
DVB DVB 
Concentration (mg/mL) 0.345 0.572 
Amount connected (mg) 0.431 1.144 
 
Octadecyl Octadecyl 
Concentration (mg/mL) 0.348 0.395 
Amount 0.435 0.79 
 
Epoxy Methacylate Epoxy Methacrylate 
Concentration (mg/mL) 0.822 0.745 
Amount connected (mg) 0.86 1.01 
 
Epoxy Butyl Epoxy Butyl 
Concentration (mg/mL) 0.759 0.394 
Amount connected 0.981 1.71 
 
Even though the binding of enzyme was very successful, no product was observed when 
used in enzymatic reaction. Two hypothesis are that either enzyme lost activity during binding 
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due to the destruction of 3D structure or enzyme link was too short or hydrophobic to dissolve in 
solution for enzymatic reaction. 
2.5.7 Large Scale Fermentation Production of GDP-Fucose 
Automation system is the new frontier research direction of science.50 The decrease of manual 
human labor will not only decrease cost but also increase efficiency. A fermenter is a highly 
automated machine that can monitor and adjust spin speed, pH and temperature. The idea is to 
use our fermenter for dual purpose, one is to express the enzyme needed for our enzymatic 
reaction and the other is to monitor and adjust the reaction condition of the nucleotide sugar 
production reaction. An enzymatic reaction is highly depended of the reaction pH and 
temperature. With the automation system of the fermenter, the pH and temperature can be 
monitored and adjusted automatically without constant manual check.  
Enzyme Expression Using Fermentation Method 
Bioreactor cultivation was performed in a 1.5 L fermenter with standard control units 
(Biostat B, Braun Biotech, Melsungen, Germany). The reconstructed strains contain 
corresponding enzymes were incubated at 37 °C, 180 rpm with 50 mL shake flask for 12 h. The 
entire 50 mL inoculum was transferred into the fermenter containing 1 L medium (2.2 g 
KH2PO4, 4.5 g (NH4)2SO4, 20 g glycerol, 13 ml MgSO4, 0.5 mL CaCl2) with 100 mg/mL 
ampicillin. The culture temperature was 37 °C and dissolved oxygen set-point was set as 30%. 
The culture pH was maintained at 7.0 and 30 % ammonium hydroxide was used to adjust the pH. 
When the OD reached 20 (about 20 h), the temperature was changed to 24 °C and all other 
conditions were maintained. Then 0.5 mM IPTG was added to induce the enzyme expressed and 
the feeding medium consisted of 10 g (NH4)2HPO4, 2 g NaH2PO4, 2.5 g (NH4)2SO4 and 50% 
glycerol was feed with 20 mL/h flow rate. Cells were harvested at 45 h. The growth of cells is 
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monitored through the OD value of the solution. Below is a figure using FKP expression as 
example. 
 
Figure 25 Fermentation of FKP Monitoring OD Value over Time. 
 After FKP is expressed, E. coli cell were collected and freeze thawed for release of FKP 
enzyme. Then fucose, ATP, GTP were added to fermenter for a final volume of 850 ml with 
concentration at 15 mM. Due to the amount of salt already within the cell system, MgCl2 as 
metal ion is added to a final concentration of 10 mM. PH is then adjusted by NaOH to 8.0. 
Further automatic adjusting is done by 6 M NH4OH. Antibiotics were added to the reaction 
solution to prevent the growth of bacteria. Reaction is kept at 37°C with a spin rate of 90 rounds 
per minute. The whole reaction was done over the course of 48 hours and monitored by TLC 
plate. 
 Final concentration of GDP-Fuc after reaction was done by capillary electrophoresis. 
Standard curve was done by pure GDP. 
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Table 4 Peak area of GDP with different concentration for the construction of standard curve 
Concentration Peak Area 
5 mM 10,085,540 
25 mM 25,702,907 
50 mM 51,760,387 
100 mM 95,167,175 
GDP-Fucose reaction ~9.7 mM 13,777,662 
 
 
Figure 26 Standard curve for quantitative analysis of GDP-Fuc 
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2.6 Experimental 
2.6.1 One Pot Multienzyme Synthesis of UDP-GlcA 
All sugar nucleotide synthesis have been conducted multiple times using the OPME 
system. Here I will use the OPME synthesis of UDP-GlcA as an example. All enzymes were 
expressed and purified by previous reported method.  
A total of 40 mL reaction system was set up containing 22 mM GlcA, 20 mM ATP, 20 
mM UTP, 100 mM Tris-HCl pH 8.0, 20 mM MgCl2 and 1 mg of GlcAk, 1 mg of USP and 0.3 
mg of PPA. The reaction mixture was put in a 37 degrees shaker for overnight shake. Reaction 
was monitored by thin layer chromatography (V:V:V Isopropanol:NH4OH:H2O=7:3:2). After 18 
hours. Reaction was stopped by heating at 90 degrees for 10 min. Enzyme was removed by 
centrifuge and solution was concentrated to 2 mL for size exclusion chromatography. Product 
was collected and lyophilized. A total of 322 mg was synthesized with a yield of 62.3%. 
2.6.2 Fermentation for the Synthesis of GDP-Fucose 
Initial growth of recombinant E. coli is done in 50 mL LB Broth medium. 5 L of stock 
E. coli solution which can express the FKP enzyme and 100 μg/mL ampicillin were added to 
the medium solution. Flask was placed in 180 RPM shaker under 37 °C for overnight growth. 
After 16 hours, all 50 mL solution were transferred to the fermenter.  
Bioreactor cultivation was continue performed in a 1.5 L fermenter with standard control 
units (Biostat B, Braun Biotech, Melsungen, Germany). The fermenter contains 1 L medium (2.2 
g KH2PO4, 4.5 g (NH4)2SO4, 20 g glycerol, 13 ml MgSO4, 0.5 mL CaCl2) with 100 mg/mL 
ampicillin. The culture temperature was 37 °C and dissolved oxygen set-point was set as 30%. 
The culture pH was maintained at 7.0 and 30 % ammonium hydroxide was used to adjust the pH. 
When the OD reached 20 (about 20 h), the temperature was changed to 24 °C and all other 
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conditions were maintained. Then 0.5 mM IPTG was added to induce the enzyme expressed and 
the feeding medium consisted of 10 g (NH4)2HPO4, 2 g NaH2PO4, 2.5 g (NH4)2SO4 and 50% 
glycerol was feed with 20 mL/h flow rate. Cells were harvested at 45 h. The growth of cells is 
monitored through the OD value of the solution. 
After cells were harvested, the cells were resuspended in cold Tris-HCl pH 8.0 buffer. 
The cell wall were broken by The French pressure cell press (French Press). After centrifugation 
(13000 RPM, 4 °C, 30 min) of the cell lysate, the supernatant was collected and stored in 4 °C. 
A total of 850 mL GDP-Fucose solution was set up using fermenter as reaction system. 
First, 2.8 g fucose, 9 g ATP, 9 g GTP, and 1.7 g MgCl2*6H2O were carefully weighed out and 
added to 600 mL DI water in a beaker. PH of the solution was adjusted by adding solid NaOH 
till 8.0. Afterwards, whole solution was transferred to fermenter, and previously expressed FKP 
supernatant is added to the solution with 100 μg/mL ampicillin and kanamycin. Finally, the 
whole volume is adjusted to 850 mL with DI water. Reaction is done at 37 °C with 90 RPM stir, 
pH is automatically adjusted by 6M NH4OH to stabilize at 8.0. Reaction is monitored by TLC 
and when almost no more fucose is observed, the reaction was stopped by adding equivalent 
volume of pure ethanol. Whole solution is transferred to a beaker and placed in -20 °C for 6 
hours. Precipitation was removed by centrifuge and the supernatant was concentrated. Partial 
solution was purified by P2 column for quantitative analysis, rest is stored at 4 °C. 
2.7 Conclusion 
In summary, two methods of enzymatic synthesis of nucleotide sugar has been 
investigated and compared. The fermentation method provides a better automation system which 
greatly reduces the amount of manual work. With the help of fermenting excess enzymes, the 
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reaction can be done at a much larger scale with relative high yield. With smaller reaction size, 
the yield is higher and the purification process is much easier. 
A total of four purification process was used during the experiment. For just P2 
purification, it is well suited for small reactions with excess sugar to deplete as much nucleotide 
as possible. For CIP digestion then P2 column, it is best suited for reactions with lower yield and 
have excess nucleotide that is hard to separate by column. With precipitation method, excess 
amount of ions are added and are hard to rid of which can cause problem in future experiments 
and NMR. Ionic exchange chromatography and P2 combined is great for large scale purification. 
Even though enzyme immobilization didn’t work, it shows great potential for future 
exploration. Finding the right resin and solving this problem can greatly reduce the amount of 
work needed for enzyme expression and purification. 
Table 5 Sum up of synthesized sugar nucleotide with enzyme 
Compound Starting Material Kinase Pyrophosphorylase PPA 
UDP-Glc Glc-1-P None USP Yes 
UDP-Gal Gal GalK USP Yes 
UDP-GlcNAc GlcNAc NahK GlmU Yes 
UDP-GalNAc GalNAc NahK GlmU Yes 
UDP-GlcA GlcA GlcAK USP Yes 
UDP-GalA GalA GalK USP Yes 
GDP-Fuc Fuc FKP FKP Yes 
GDP-Man Man NahK ManC Yes 
CMP-Neu5Ac Neu5Ac None CSS Yes 
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3 CHAPTER 3. SYNTHESIS OF LEWIS-X CONTAINING OLIGOSACCHARIDE 
LACTO-N-FUCOPENTAOSE III 
3.1 Introduction 
Lacto-N-fucopentaose III (LNFPIII) was initially discovered by using monoclonal 
antibodies reactive to Schistosomiasis Mansoni soluble egg antigen (SEA). It is also contained in 
human milk and it contains the trisaccharide structure of Lewis X.51 
Such Lewis antigens family structure are found largely in the human body.52, 53 Among 
these structure, many has been confirmed to have the ability to bind with pathogenic bacteria for 
initial infection.  
LNFP III has previously been shown therapeutic action for metabolic and autoimmune 
diseases and prolongs transplant survival in mice. Prof. Chi-Hao Lee from Harvard also 
demonstrated how LNFP III have the potential to treat metabolic diseases.54 
In collaboration with Prof. Lee, from his result showing that LNFP III giving to diet-
induced mice can increase their glucose tolerance and insulin sensitivity. This effect is caused by 
the increase of interleukin-10 (Il-10), because LNFP III reduced tissue inflammation and 
increase the response of adipocytes to insulin. Also, LNFP III shows the potential to treat 
nonalcoholic fatty liver disease. 
Protein Arginase 1 (Arg1) plays an important role in the human urea cycle in converting L-
arginine to urea and L-ornithine. LNFP III treatment can upregulate the expression of Arg1. A 
deficiency in Arg1 expression can cause Argininemia. Tumor necrosis factor (TNF) is in 
charge of regulating immune cells. It is able to induce fever and inflammation to inhibit 
tumorigenesis and viral replication. As LNFP III can suppress the expression of TNF, it is able to 
help with inflammation within the mice. 
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During the collaboration, it is my duty to synthesize LNFP III in hundred milligram scale 
for further testing and conjugation with carrier molecules. Although previous chemical synthesis 
of LNPFIII derivatives have been reported by Sinay55 and Zhang.56 It is much too complex and 
inefficient compared with biological process has been proven to be much more efficient and easy 
to operate. 
There are two kinds of glycosyltransferases (GTs) that are key enzymes in the synthesis of 
carbohydrates. One is the Leloir-type GTs named after Noble Prize Winner Luis F. Leloir for his 
discovery of the first sugar nucleotide.57 The Leloir-type GTs are the majority of GTs found in 
nature, it requires sugar nucleotide as the essential building block.58 The other kind is non-Leloir 
glycosyltransferases which uses non nucleotide donors. 
3.2 Enzymatic Synthesis of Sugar Nucleotide 
For the production of sugar nucleotide is similar to previously introduced methods. 22 mM 
monosaccharide was added with 20 mM ATP and 20 mM NTP under pH 8.0 with 20 mM Mg2+ 
and 0.1 M Tris-HCl is used to stabilize the pH during reaction. With all chemicals added and pH 
adjusted. Kinase, transferase and PPA enzymes were then added to the solution. After overnight 
reaction, more enzymes were added to push the reaction more to completion. After 20-24 hours, 
pH was adjusted to around 9, then alkaline phosphate (CIP) enzyme was added to digest the 
unreacted ATP, NTP and other byproduct. Ethanol was added 1:1 ratio to the reaction solution to 
precipitate all protein. Afterwards, the solution was concentrated and purified by P2 biogel and 
freeze dried.  
3.3 Small Scale Synthesis of Lacto-N-fucopentaose III 
The synthesis of LNFP III (Figure 18) consist of 3 steps starting from lactose. Compared 
with chemical method, biological method is much easier and time saving. Using the purified 
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sugar nucleotide method only three steps are need. Each step was done individually and 
purification was needed for every reaction. Because it’s the initial try for synthesis of LNFP III, 
only hundred milligram scale reaction was set up. 
 
Figure 27 Reaction scheme for the synthesis of LNFP III 
3.3.1 Synthesis of LNT II trisaccharides 
For the production of LNT II trisaccharide, lactose and equivalent molar of UDP-GlcNAc 
were added. LgtA enzyme was used as the transferase to add GlcNAc to the  1-3 position.59 
Magnesium chloride and Tris-HCl was added at a final concentration of 0.02 M and 0.1 M. The 
reaction system was kept at 37 degrees water bath. After overnight reaction, more enzymes was 
added to the reaction for another 6 hours. Due to the low activity of LgtA because of the short 
chain, more enzymes are usually needed to push the reaction to completion. Reactions were 
monitored through Matrix-assisted laser desorption/ionization (MALDI). After reaction, the 
reaction system was put in 90 degrees water for 10 min then it was centrifuged to remove all 
proteins. Purification was done using P2 Biogel. After purification and lyophilization the product 
was collected.  
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Figure 28 Reaction scheme for the synthesis of LNT II trisaccharide 
3.3.2 Synthesis of LNnT tetrasaccharide 
For the synthesis of tetrasaccharide, I started with LNT II purified from previous reaction 
and added same molar of UDP-Gal. LgtB enzyme was used as the transferase to add Gal to the 
 1-4 position.60 Magnesium chloride and Tris-HCl was added at a final concentration of 0.02 M 
and 0.1 M. The reaction system was kept at 37 degrees water bath. After overnight reaction, 
more enzymes was added to the reaction for another 6 hours. Reactions were monitored through 
Matrix-assisted laser desorption/ionization (MALDI). After reaction, the reaction system was put 
in 90 degrees water for 10 min then it was centrifuged to remove all proteins. Purification was 
done using P2 Biogel. After purification and lyophilization the product was collected.  
 
Figure 29 Reaction scheme for the synthesis of LNnT tetrasaccharide 
3.3.3 Synthesis of LNFP III Pentasaccharide 
For the synthesis of LNFP III, I started with the tetrasaccharide purified from previous 
reaction and added 0.95 equivalence molar of GDP-Fuc.  1,3 FucT enzyme was used as the 
transferase to add Fuc to the  1-3 position. After fucose is added to the GlcNAc, if there is 
excess GDP-Fuc, it will add to the  1-3 position of glucose.61 That is why in this reaction, the 
tetrasaccharide is at excess (Figure 22). Magnesium chloride and Tris-HCl was added at a final 
concentration of 0.02 M and 0.1 M. The reaction system was kept at 37 degrees water bath. After 
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overnight reaction, more enzymes was added to the reaction for another 6 hours. Reactions were 
monitored through Matrix-assisted laser desorption/ionization (MALDI). After reaction, the 
reaction system was put in 90 degrees water for 10 min then it was centrifuged to remove all 
proteins. Purification was done using P2 Biogel. After purification and lyophilization the product 
was collected. 
 
Figure 30 Reaction scheme for the synthesis of LNFP III pentasaccharide 
 
Figure 31 MALDI-TOF result of LNFP III with excess GDP-Fucose 
3.4 Conjugation of Lacto-N-fucopentaose III on to linker 
In collaboration with Prof. Chih-Hao Lee from Harvard, we conjugated LNFP III with 
many carrier to test their immune response. Reaction were done by other members of our lab. 
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We successfully linked LNFP III to dextran, HAS and BSA. Then compounds were send to Prof. 
Chih-Hao Lee at Harvard for mice test. 
 
Figure 32 Reaction Scheme for conjugating LNFP III to dextran 
 
Figure 33 M0 gene expression following 24 hour treatment with sugars 
  
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
IL-10 Arg-1 TNFa
fo
ld
 c
h
an
ge
control
LNFP III (1:1000)
Dextran-Maltose (1:1000)
Dextran-Maltose (1:500)
Dextran-LNFP III 3-6 (1:1000)
Dextran-LNFP III 3-6 (1:500)
Dextran-LNFP III 15-19 (1:1000)
Dextran-LNFP III 15-19 (1:500)
Dextran-LNFP III 15-19 (1:2000)
HAS-LNFP III (1:500)
BSA-LNFP III (1:1000)
BSA-LNFP III (1:500)
57 
3.5 LNT II Trisaccharide production through fermentation method 
3.5.1 Materials and Methods 
Strain and plasmid 
LgtA-pET15b plasmid was transformed into E. coli JM109 (DE3) competent cells. the E. 
coli JM109 (DE3) which is lacY+ and lacZ- harboring lgtA-pET22b plasmid was used for LNT-
II production. Selected colonies were grown overnight in Luria-Bertani media. 
Media and culture conditions 
The seed culture: the strain was adapted to 50 mL minimal salt medium (KH2PO4 7.8 
g/L, Citric acid 1 g/L, (NH4)2SO4, 2.33 g/L, Trace metal solution 1 ml/L, Glycerol 22 g/L, 
MgSO4·7H2O 1 g/L, CaCl2 40 mg/L, Ampicillin 100 mg/L) shaking at 200 rpm overnight at 
37°C, transferred to 500 mL minimal salt medium, and grown for 12 h until OD600 = 2.5. 
The 2 L fermenter culture: the fermenter culture was used to seed 2 L batch medium 
(KH2PO4 2.2 g/L, Citric acid 1 g/L, (NH4)2SO4, 4.5 g/L, Trace metal solution 1 ml/L (EDTA 5 
g/L, FeSO4 ·7H2O 10 g/L, ZnSO4 ·7H2O 2 g/L, MnSO4·H2O 2 g/L, CoCl2·6H2O 0.2 g/L, CuSO4 
·H2O 0.1 g/L, Na2MoO4 ZnSO4 ·2H2O 0.2 g/L, H3BO3 0.1 g/L), Thiamine HCl 10 mg/L, 
Glycerol 22 g/L, MgSO4 1 g/L, CaCl2 40 mg/L, Antifoam 204 75 µL/L, Ampicillin 100 mg/L) in 
B. Braun (Sartorius) Biostat® B stirred tank bioreactor at 37°C, pH maintained at 7.0 with 6 M 
NH3·H2O. Upon glycerol exhaustion, temperature was reduced to 26°C and lactose and IPTG 
were added in the medium at a concentration of 5 g/L and 0.5 mM respectively. 
In addition, feed medium KH2PO4 1.5 g/L, (NH4)2HPO4 10 g/L, NaH2PO4 4 g/L, 
(NH4)2SO4 5 g/L, Citric acid 1 g/L, Trace metal solution 6 ml/L (EDTA 5 g/L, FeSO4 ·7H2O 10 
g/L, ZnSO4 ·7H2O 2 g/L, MnSO4·H2O 2 g/L, CoCl2·6H2O 0.2 g/L, CuSO4 ·H2O 0.1 g/L, 
Na2MoO4 ZnSO4 ·2H2O 0.2 g/L, H3BO3 0.1 g/L), Thiamine HCl 50 mg/L, Glycerol 200 g/L, 
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MgSO4·7H2O 4.6 g/L, CaCl2 2 mg/L, Antifoam 204 75 µL/L, Lactose 10 g/L) was added at a 
rate of 120 mL/h in the first 3 hours. Feed rate was changed to 90 mL/h for lower feeding rate of 
substrate. Samples were taken in triplicate and analyzed for yield LNT-II yield and cell dry 
weight (CDW). 
3.5.2 Fed-batch fermentation procedure 
(1) Put 0.8 L batch medium into the fermenter, the final volume is 2 L batch medium, pH 7.0; 
(2) Transfer 25 ml OD600=2.5 E. coli seed into 2 L batch medium, The temperature is 37oC and 
pH is 7.0; 
(3) The first exponential growth phase last until exhaustion of the carbon substrate, both lactose 
(5 g/L) and inducer (IPTG 0.5 mM) were added at the end of the exponential phase. The 
temperature is 26 oC and pH is 7.0; 
(4) 3 h fed-batch with high rate, the total volume is 360 ml; 
(5) 25-30 h fed-batch with low rate, the total volume is 500 ml. 
3.5.3 Fermentation production of LNT II Trisaccharide 
This work was done in collaboration with another lab member (Zhigang Wu). E. coli 
string JM 109 was fermented using above procedure. The schematics is shown as in figure 25. 
 
Figure 34 Schematics for E. coli JM 109 to synthesize LNT II trisaccharide 
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Purification was done using activated charcoal combined with P2 SEC. First charcoal 
was activated by pure methanol. Then deionized water is used to wash the charcoal. Sample is 
then loaded onto the column (around 1.2 g on to 80 g charcoal). Then the column was washed 
with deionized water for 800 mL. Then 800 mL 5% ethanol was used to wash away impurities. 
Lastly, the trisaccharide is eluted with 800 mL 50% ethanol. The recovery rate is around 60% 
determined by HPLC. Then the collected fraction was concentrated and loaded onto P2 column 
for further purification. 
There are many advantages to the fermentation method. First, no UDP-GlcNAc is needed 
for the reaction system, because lactose was transported into the cell then used the UDP-GlcNAc 
produced by the cell for the reaction. Secondly, reaction could be done at a large scale with 
excess enzyme to push the reaction forward. Third, no purification of the enzyme is needed. 
3.6 High Performance Liquid Chromatography 
High Performance Liquid Chromatography (HPLC) is an analytical technique often used to 
separate compounds within a mixture. Separation is usually done by the combination of the 
stationary phase and mobile phase. 
In my work, I use a binary gradient from 80% acetonitrile to 60% in a course of 45 min. The 
detection is done by an ELSD detector. The retention time of LNT II, LNnT, and LNFP III are 
20 minute, 25 minute and 30 minutes. 
3.7 ELSD 
Evaporative light scattering detector (ELSD) often used for HPLC when UV-Vis can’t be 
used to detect the analyte such as sugar. When the flow through passes the ELSD detector, the 
solvent is evaporated off leaving the analyte. Then the analyte passes through a tube by carrier 
gas and a light shine through it. Then the scatter of the light is measured. 
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3.8 One Pot Multienzyme Synthesis of LNFP III 
3.8.1 Synthesis of LNnT tetrasaccharide 
For the synthesis of tetrasaccharide, I started with LNT II purified from previous 
fermentation method, and added equivalent molar of ATP, UTP and Gal. A total of four enzymes 
were added to the reaction (GalK, USP, PPA, and LgtB). Magnesium chloride and Tris-HCl was 
added at a final concentration of 0.02 M and 0.1 M. The reaction system was kept at 37 degrees 
water bath. After overnight reaction, more enzymes was added to the reaction for another 6 
hours. Reactions were monitored through Matrix-assisted laser desorption/ionization (MALDI). 
After reaction, the reaction system was put in 90 degrees water for 10 min then it was 
centrifuged to remove all proteins. Purification was done using P2 Biogel. After purification and 
lyophilization the product was collected.  
 
Figure 35 Reaction scheme for the OPME synthesis of LNnT tetrasaccharide 
3.8.2 Synthesis of LNFP III Pentasaccharide 
For the synthesis of LNFP III, I started with the tetrasaccharide purified from previous 
reaction and added equivalent molar of ATP, GTP and Fucose. A total of three enzymes were 
added to the reaction (FKP, PPA, and  1,3 FucT). Magnesium chloride and Tris-HCl was added 
at a final concentration of 0.02 M and 0.1 M. The reaction system was kept at 37 degrees water 
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bath. After overnight reaction, more enzymes was added to the reaction for another 6 hours. 
Reactions were monitored through Matrix-assisted laser desorption/ionization (MALDI). After 
reaction, the reaction system was put in 90 degrees water for 10 min then it was centrifuged to 
remove all proteins. Purification was done using P2 Biogel. After purification and lyophilization 
the product was collected. 
 
Figure 36 Reaction scheme for the OPME synthesis of LNFP III pentasaccharide 
3.9 LNnT Tetrasaccharide Production Through Fermentation Method 
With fermentation method of LNT II trisaccharide being a success, it is easy to try to 
move one step further with the fermentation of LNnT. The advantages of doing so is to skip the 
tedious purification step of LNT II and straightly use it for the synthesis of LNnT. 
Due to the complexity of the reaction system, it is wise to synthesize sugar nucleotides 
beforehand. So we also combine the fermentation method of producing sugar nucleotide into the 
synthesis of LNnT. 
First, all enzymes (GalK, USP, PPA, and LgtB) were individually fermented and kept at -
80 degress. Then using the French press to break the cell wall of all enzymes, by simple 
centrifuging to dispose of the cell, enzymes were released into the buffer liquid. 
Then ATP, UTP, Gal, MgCl2 and antibiotics were added to the fermenter. PH was 
initially adjusted to 8.0 by NaOH. Then automatically kept at 8.0 by 6 M ammonium hydroxide. 
62 
The reaction were kept at 37°C with a spin rate of 90 spins per minute. Reaction was done over a 
course of 36 hours with monitoring from TLC. During the time, more enzyme was added every 
10-12 hours. 
After UDP-Gal was synthesized, concentrated LNT II trisaccharide with LgtB enzyme 
was added to the reaction solution. The reaction were kept at 37°C with a spin rate of 90 spins 
per minute. The reaction was done over the course of 26 hours when no further LNnT was 
produced. 
 
Figure 37 Impure LNT II trisaccharide before the reaction 
 
 
Figure 38 LNnT reaction after 26 hours 
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3.10 LNFP III with N3 linker 
With previous study of LNFP III conjugate showing not very positive result, it has been 
considered that it might have been cost by the fact that the first sugar glucose ring was destroyed 
during conjugation. Here I propose to synthesize LNFP III with an already attached linker. The 
initial Lactose-N3 was provided by other lab members. Since the reaction scale is small for initial 
testing, the reaction was done using sugar nucleotides. After three steps, the proposed compound 
was synthesized and detected by MALDI-TOF. 
 
Figure 39 Reaction scheme for the synthesis of LNFP III with a N3 linker 
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Figure 40 MALDI-TOF detection of LNFP III with linker 
3.11 Experimental 
Synthesis of LNFP III was performed multiple times with different method. Here I will 
report one in detail using the OPME method. All enzymes were expressed and purified by 
previous reported method. 
LNT II trisaccharide was previously synthesized by fermentation method and purified by 
activated carbon and SEC.  
A total of 40 mL solution for the synthesis of LNnT tetrasaccharide was set up. 430 mg 
of LNT II trisaccharide was weighed out and dissolved in 30 mL solution. 440 mg of ATP and 
410 mg of UTP were weighed and added to the solution, pH was adjusted to 8.0 using NaOH. 
Then 150 mg of galactose was added to the solution. Finally, 4 mL of 200 mM MgCl2 stock 
solution and 4 mL 1M Tris-HCl pH 8.0 buffer was added to the solution. Reaction was started by 
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adding previously purified GalK (3 mg), USP (3 mg), PPA (0.1 mg) and LgtB (5 mg) enzymes. 
Final volume was brought to 40 mL with DI water. Reaction was monitored by TLC, when most 
of LNnT was reacted, reaction was stopped by heating at 90 °C for 10 min to precipitate enzyme. 
Precipitation was removed by centrifuge at 6800 RPM for 15 min. Then solution was 
concentrated to 2 mL and loaded onto P2 column. Fractions containing LNnT tetrasaccharide 
was collected and concentrated for lyophilization. A total of 326 mg of LNnT was collected with 
a yield of 58.4%. 
Previously synthesized LNnT was used to synthesize LNFP III. 300 mg of LNnT was 
weighed and dissolved in 15 mL solution. 240 mg of ATP and 250 mg of GTP were weighed and 
added to the solution, pH was adjusted by NaOH to 8.0. Then 75 mg of fucose with 2.2 mL of 
200 mM MgCl2 stock solution and 2.2 mL 1M Tris-HCl pH 8.0 buffer was added to the solution. 
Reaction was initiated by the addition of FKP (3 mg), PPA (0.1 mg) and  1,3 FucT (3 mg). 
Reaction was monitored by TLC and MALDI-TOF. More enzymes (FKP and FucT, 1 mg each) 
were added after 16 hours. Reaction was stopped when no further product was synthesized. 
Whole solution was boiled at 90 °C for 10 min to precipitate enzyme. Precipitation was removed 
by centrifuge at 6800 RPM for 15 min. Then solution was concentrated to 2 mL and loaded onto 
P2 column. Fractions containing LNFP III was collected and lyophilized. A total of 187 mg of 
LNFP III was collected with a yield of 51.6%. 
The overall yield from LNT II to LNFP III is 30.1%. 
Table 6 Stepwise yield for the synthesis of LNFP III 
Step Product Yield 
1 LNnT 58.4% 
2 LNFP III 51.6% 
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3.12 Conclusion 
LNFP III has been successfully synthesized in three methods. With direct usage of sugar 
nucleotide for initial small scale synthesis pathway study. The one pot multienzyme synthesis of 
large scale production for conjugation and mice study. And last the fermentation enzymatic 
combined synthesis. 
Initial test result for conjugated LNFP III were negative, and a new batch of LNFP III with 
premade linker and undestroyed first sugar was made. 
Overall, LNFP III shows great potential in treatment for metabolic disorders. The future of 
oligosaccharide synthesis also will rely more and more on the fermentation method for 
automation system. It greatly reduces the time and energy used to synthesized complex 
oligosaccharides with the only drawback of purification complexity. 
Over the course of many reactions, a total of around 1 gram LNFP III was synthesized. 
Table 7 Summary of synthesis of LNFP III with starting material and enzyme 
Target Compound Starting Material Kinase Pyrophosphorylase Transferase 
LNT II Lactose, GlcNAc NahK GlmU LgtA 
LNnT LNT II, Gal GalK USP LgtB 
LNFP III LNnT, Fuc FKP FKP  1,3 FucT 
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4 CHAPTER 4. SYNTHESIS OF HUMAN CANCER ANTIGEN GLOBO H 
4.1 Introduction 
Globo H is a hexasaccharide consisting of six monosaccharide (Glc 4 Gal 4 Gal 3 
GalNAc 3 Gal 2 Fuc). It is a cell surface glycosphingolipid and a member of the globo series 
of antigenic carbohydrates. In 1983, Globo H was first isolated from human MCF-7 breast 
cancer cells using the monoclonal antibody MBr162. Because of its overexpression on cancer 
cells, Globo H has been a popular cancer antigen63. The importance of Globo H has greatened 
even more because scientist has found that it is also overexpressed on cancer stem cells. 
Currently, the synthesis of Globo H is available by chemical methods64. However, through 
chemical method it both is time consuming and hard work due to the multiple 
protection/deprotection and purification steps. Also, using chemical method it is hard to achieve 
a high yield and large quantity of Globo H. In the aspect of this problem, an enzymatic synthesis 
has been proposed. In 1982, an enzymatic synthesis of Globo H was introduced by Prof. Chi-
Huey Wong65. From that time forward, many enzymatic synthesis process has been done66,67. 
Globo H uses the Leloir glycosyltransferases to synthesize enzymatically. In doing so, it 
needs the highly expensive sugar nucleotides as donors. It is much more effective and 
economically efficient to use the one pot multienzyme system previously introduced for the 
synthesis of LNFP III. 
A total of four OPME synthesis consisting of nine enzymes are used to total synthesis 
Globo H enzymatically. In doing so we avoid the high costing sugar nucleotide and start with the 
economically more affordable monosaccharide and nucleotides. 
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4.2 Small scale synthesis of Globo H 
Globo H was synthesized following the Leloir process. Through a combined of four 
enzymatic reactions, lactose was synthesized to Globo H. The chemical structure of Globo H is 
as shown below in Figure 33. 
 
Figure 41 Chemical Structure of Globo H 
4.2.1 Synthesis of Gb3 
For the synthesis of Gb3, I started with lactose and added 1.1 equivalent excess amount 
of UDP-Gal. LgtC enzyme was added to the reaction system to undergo the  1,4 reaction to 
attach gal to lactose. CIP enzyme was added to digest UDP to UMP for purification purpose. 
Tris-HCl pH 8.0 was added to the system to stabilize the pH of the reaction. MnCl2 was added 
because LgtC is more active with Mn in the reaction system.68 After all materials were added, the 
reaction system was kept in a 37 degrees water bath for overnight reaction. Reactions were 
monitored through TLC plates. After reaction, the reaction system was put in 90 degrees water 
for 5-10 min then it was centrifuged to remove all protein. Purification was done using P2 Biogel 
and eluent was collected for lyophilization. 
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Figure 42 Reaction scheme for the synthesis of Gb3 
4.2.2 Synthesis of Gb4 
For the synthesis of Gb4, I started with Gb3 and added equivalent amount of UDP-
GalNAc. LgtD enzyme was added to the reaction system to undergo the  1,3 reaction to attach 
GalNAc to Gb3. CIP enzyme was added to digest UDP to UMP for purification purpose. Tris-
HCl pH 8.0 was added to the system to stabilize the pH of the reaction. MnCl2 was added 
because LgtD is more active with Mn in the reaction system.69 After all materials were added, 
the reaction system was kept in a 37 degrees water bath for overnight reaction. Reactions were 
monitored through TLC plates. After reaction the solution was collected for further reaction. 
 
Figure 43 Reaction scheme for the synthesis of Gb4 
4.2.3 Synthesis of Gb5 
For the synthesis of Gb5, I started with Gb4 reaction solution and added equivalent 
amount of UDP-Gal. LgtD enzyme was added to the reaction system to undergo the  1,3 
reaction to attach Gal to Gb4.70 Due to the same reaction enzyme is used for Gb4 and Gb5 
synthesis, there is no need to purify in between. Also a benefit of using sugar nucleotides instead 
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of OPME reaction. CIP enzyme was added to digest UDP to UMP for purification purpose. Tris-
HCl pH 8.0 was added to the system to stabilize the pH of the reaction. MnCl2 was added 
because LgtD is more active with Mn in the reaction system. After all materials were added, the 
reaction system was kept in a 37 degrees water bath for overnight reaction. Reactions were 
monitored through TLC plates. After reaction is finished, the reaction system was put in 90 
degrees water for 5-10 min then it was centrifuged to remove all protein. Purification was done 
using P2 Biogel and eluent was collected for lyophilization. 
 
Figure 44 Reaction scheme for the synthesis of Gb5 
4.2.4 Synthesis of Globo H 
For the synthesis of Globo H, I started with Gb5 and added excess amount of UDP-Fuc. 
HP  1,2 FucT enzyme was added to the reaction system to undergo the  1,2 reaction to attach 
Fuc to Gb5.71 CIP enzyme was added to digest GDP to GMP for purification purpose. Tris-HCl 
pH 8.0 was added to the system to stabilize the pH of the reaction. MgCl2 was added because 
LgtD is more active with Mg in the reaction system. After all materials were added, the reaction 
system was kept in a 37 degrees water bath for overnight reaction. After reaction is finished, the 
reaction system was put in 90 degrees water for 5-10 min then it was centrifuged to remove all 
protein. Purification was done using P2 Biogel and eluent was collected for lyophilization. Final 
product was confirmed by ESI-MS as shown in figure 38. 
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Figure 45 Reaction scheme for the synthesis of Globo H 
 
Figure 46 MS spectrum of Globo H 
Globo H synthesis has been confirmed successful by a combination of MS and MS-MS. 
In figure 42, it shows peak 1016.3631 which is the MS peak for Globo H with a hydrogen 
molecule for positive charge mode. Then to confirm the structure of Globo H synthesized, MS-
MS was done. As shown in Figure 43, peak 528.4672 confirms the central structure of Gal-
GalNAc-Gal. Peak 512.4186 confirms the terminal structure of Fuc-Gal-GalNAc. 
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Figure 47 MS-MS confirmation of Globo H 
4.3 One pot multienzyme synthesis of Globo H 
4.3.1 OPME Synthesis of Gb3 
Equimolar of Lactose, galactose, ATP and UTP were added to the reaction system. Then 
Tris-HCl pH 8.0 was added to stabilize the pH. MnCl2 was added to the reaction for improving 
the enzyme activity. Then LgtC, GalK and USP enzymes were added to the reaction. Reaction 
was kept in 37 degree water bath for overnight. After overnight reaction, more enzymes were 
added to the reaction for another overnight. After the reaction is finished, the system was heated 
in 90 degrees water for 10 min, then it was centrifuged and disposed of the solid. This step was 
done between each reaction step. 
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Figure 48 Reaction scheme for the OPME synthesis of Gb3 
4.3.2 OPME Synthesis of Gb4 
Equimolar of Lactose, galactose, ATP and UTP were added to the reaction system. Then 
Tris-HCl pH 8.0 was added to stabilize the pH. MnCl2 was added to the reaction for improving 
the enzyme activity. Then LgtC, GalK and USP enzymes were added to the reaction. Reaction 
was kept in 37 degree water bath for overnight. After overnight reaction, more enzymes were 
added to the reaction for another overnight. After the reaction is finished, the system was heated 
in 90 degrees water for 10 min, then it was centrifuged and disposed of the solid. This step was 
done between each reaction step. 
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Figure 49 Reaction scheme for the OPME synthesis of Gb4 
4.3.3 OPME Synthesis of Gb5 
Equimolar of Lactose, galactose, ATP and UTP were added to the reaction system. Then 
Tris-HCl pH 8.0 was added to stabilize the pH. MnCl2 was added to the reaction for improving 
the enzyme activity. Then LgtC, GalK and USP enzymes were added to the reaction. Reaction 
was kept in 37 degree water bath for overnight. After overnight reaction, more enzymes were 
added to the reaction for another overnight. After the reaction is finished, the system was heated 
in 90 degrees water for 10 min, then it was centrifuged and disposed of the solid. This step was 
done between each reaction step. 
 
Figure 50 Reaction scheme for the OPME synthesis of Gb5 
4.3.4 OPME Synthesis of Globo H 
Equimolar of Lactose, galactose, ATP and UTP were added to the reaction system. Then 
Tris-HCl pH 8.0 was added to stabilize the pH. MgCl2 was added to the reaction for improving 
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the enzyme activity. Then  1,2 FucT and FKP enzymes were added to the reaction. Reaction 
was kept in 37 degree water bath for overnight. After overnight reaction, more enzymes were 
added to the reaction for another overnight. After the reaction is finished, the system was heated 
in 90 degrees water for 10 min, then it was centrifuged and disposed of the solid. This step was 
done between each reaction step. 
 
Figure 51 Reaction scheme for the OPME synthesis of Globo H 
4.4 Experimental 
Synthesis of Globo H was performed by me three times in total, synthesizing a total of 
200 mg Globo H was synthesized. One whole procedure will be described in detail. All enzymes 
were expressed and purified by previous reported method. 
A total 40 mL reaction was set up for the synthesis of GB3. 274 mg of lactose was 
carefully weighed and placed in a 50 mL tube. 20 mL DI water was added to dissolve lactose 
fully. Then 500 mg of UDP-Gal was carefully weighed and added to the solution. 4 mL of 200 
mM MnCl2 stock solution and 4 mL 1M Tris-HCl pH 8.0 buffer was added to the solution. After 
mixing solution well and all compounds dissolved, 30 Units of LgtC was added to the solution 
and then total volume was brought to 40 mL by DI water. Reaction was done in a 37 degrees 
incubator. Reaction was monitored by thin-layer chromatography (isopropanol/H2O/ammonium 
hydroxide = 7:3:2 (v/v/v)). After reaction is done, tube was placed in 90 degrees water bath for 
10 min to precipitate out the enzyme. After removal enzyme by centrifuge (6800 RCF, 20 min), 
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solution was concentrated to 2 mL and loaded onto the P2 column. A total of 370 mg GB3 was 
collected and yield was 91.9%. 
A total 18 mL reaction was set up for the synthesis of GB4. 180 mg of previously 
synthesized GB3 was added to 10 mL DI water. 240 mg of UDP-GalNAc was added to the 
solution and mixed well. Then 1.8 mL of 200 mM MnCl2 stock solution and 1.84 mL 1M Tris-
HCl pH 8.0 buffer was added to the solution. 15 Units of LgtD was added to the solution and 
total volume was adjusted to 18 mL. Reaction was placed in 37 degrees incubator and monitored 
by TLC. After purification, 157 mg of GB4 was collected with a yield of 62.2% 
A total of 7.5 mL reaction was set up for the synthesis of GB 5. 100 mg of purified GB4 
was added to 4 ml of DI water. 90 mg of UDP-Gal was weighed and added to the solution. Then 
0.75 mL of 200 mM MnCl2 stock solution and 0.75 mL 1M Tris-HCl pH 8.0 buffer was added to 
the solution. 8 Units of LgtD was added to the solution and total volume was adjusted to 7.5 mL. 
Reaction was placed in 37 degrees incubator and monitored by TLC. A total of 90 mg GB5 was 
synthesized with a yield of 73.2%. 
A total of 3.5 mL reaction was set up for the synthesis of Globo H. 60 mg of synthesized 
GB5 was added to 2 mL DI water. 50 mg of GDP-Fuc was added to the solution. Then 0.35 mL 
of 200 mM MgCl2 stock solution and 0.35 mL 1M Tris-HCl pH 8.0 buffer was added to the 
solution. 4 Units of  1,2 FucT was added and total volume was adjusted to 3.5 mL. Reaction 
was done in a 37 degrees incubator and monitored by TLC. Finally a total of 58 mg Globo H was 
purified and collected. Confirmation was done by mass spectrometry and HNMR. The yield is 
82.8%.  
The overall yield is 34.6% from conversion of lactose to Globo H.  
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Table 8 Stepwise yield for the synthesis of Globo H 
Step Product Yield 
1 Gb3 91.9% 
2 Gb4 62.2% 
3 Gb5 73.2% 
4 Globo H 82.8% 
  
78 
4.5 Conclusion 
In this chapter, I report two enzymatic synthetic route to obtain Globo H with lactose as the 
starting material. One using the Leloir process, and the other using OPME method. Both method 
have their advantages and disadvantages. 
For Leloir process, the reaction rate is faster and yield is higher. Also using sugar 
nucleotide directly can combine both LgtD reactions together without purification. For OPME 
method, skipping the tedious sugar nucleotide production step and purification can be more time 
efficient.  
A total of 200 mg Globo H was synthesized through a series of three whole synthesis. 
Table 9 Summary of synthesis of Globo H with starting material and enzyme 
Target Compound Starting Material Kinase Pyrophosphorylase Transferase 
Gb3 Lactose, Gal GalK USP LgtC 
Gb4 Gb3, GalNAc NahK GlmU LgtD 
Gb5 Gb4, Gal GalK USP LgtD 
Globo H Gb5, Fuc FKP FKP  1,2 FucT 
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APPENDIX FOR CHAPTER 2 
UDP-GlcNAc 
 
MALDI-TOF result for UDP-GlcNAc 
 
CE Result for UDP-GlcNAc 
89 
UDP-GalNAc 
 
MALDI-TOF result for UDP-GalNAc 
 
CE result for UDP-GalNAc 
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UDP-Glc 
  
MALDI-TOF result for UDP-Glc 
 
 
CE data for UDP-Glc  
654.719
632.753
538.020
0
500
1000
1500
In
te
n
s
. 
[a
.u
.]
400 500 600 700 800 900 1000 1100
m/z
91 
UDP-Gal 
 
MALDI-TOF result for UDP-Gal 
 
CE result for UDP-Gal 
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GDP-Fucose 
 
MALDI-TOF result for GDP-Fucose 
 
CE Result for GDP-Fucose 
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GDP-Man 
 
ESI-MS for GDP-Mannose 
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UDP-GlcA 
 
MALDI-TOF result for UDP-GlcA 
 
CE result for UDP-GlcA 
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GDP-Fucose standard curve using GDP as standard 
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Comparison of CIP digestion and ionic exchange chromatography purity 
 
Purified by CIP digestion combined with P2 
 
Purified by Ionic exchange chromatography combined with P2 
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BCA standard curve for quantification of enzyme 
 Concentration absorbance 
BCA Standard 0 0.07 
 0.125 0.133 
 0.25 0.205 
 0.5 0.324 
 0.75 0.445 
 1 0.54 
 1.5 0.761 
 2 0.912 
   
NAHK (5mg/ml) 3.63 1.645 
 2.86 1.317 
AGX1 (2mg/ml) 2 0.912 
 1.19 0.603 
 
UDP-GalNAc test with immobilized enzyme 
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APPENDIX FOR CHAPTER 3 
 
MALDI-TOF of trisaccharide 
 
MALDI-TOF of tetrasaccharide 
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MALDI-TOF for unpurified LNFP III 
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LNFP III H-NMR 
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APPENDIX FOR CHAPTER 4 
Globo H H-NMR 
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Globo H MALDI-TOF 
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MS-MS result of Globo H 
